TD Waterhouse Canada’s VanEck Pharmaceutical ETF PPH Stock Holding History

TD Waterhouse Canada’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.4K	Hold	100	–	–	﹤0.01%	1744
2025 Q4	$10.3K	Sell	100 -70	-41%	-$6.81K	﹤0.01%	1537
2025 Q3	$16.1K	Hold	170	–	–	﹤0.01%	1439
2025 Q2	$15K	Hold	170	–	–	﹤0.01%	1366
2025 Q1	$15K	Hold	170	–	–	﹤0.01%	1322
2024 Q4	$14.7K	Hold	170	–	–	﹤0.01%	1340
2024 Q3	$16K	Hold	170	–	–	﹤0.01%	1270
2024 Q2	$15.6K	Hold	170	–	–	﹤0.01%	1270
2024 Q1	$18.3K	Sell	170 -270	-61%	-$23.6K	﹤0.01%	1250
2023 Q4	$36.9K	Sell	440 -82	-16%	-$6.43K	﹤0.01%	1010
2023 Q3	$41.3K	Sell	522 -19,366	-97%	-$1.56M	﹤0.01%	962
2023 Q2	$1.57M	Buy	+19,888	New	+$1.56M	0.02%	354

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

BCIM

British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return

ERSOT

Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

TD Waterhouse Canada's PPH Position: Q1 2026 in Review

TD Waterhouse Canada held its VanEck Pharmaceutical ETF (PPH) position steady in Q1 2026 at 100 shares worth $10.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1744.

TD Waterhouse Canada first reported a position in PPH in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.57M in Q2 2023. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

TD Waterhouse Canada held 100 shares of VanEck Pharmaceutical ETF worth $10.4K as of Q1 2026.
TD Waterhouse Canada left its VanEck Pharmaceutical ETF share count unchanged in Q1 2026.
VanEck Pharmaceutical ETF made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q1 2026, its #1744 holding.
TD Waterhouse Canada first reported a position in VanEck Pharmaceutical ETF in Q2 2023 and has held it in 12 quarters since.
TD Waterhouse Canada's VanEck Pharmaceutical ETF position peaked at $1.57M in Q2 2023.
147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on TD Waterhouse Canada's 13F filing for Q1 2026, filed 12 May 2026.